Cargando…

Recurrent Early Thrombus Formation in HeartMate II Left Ventricular Assist Device

Left ventricular assist devices are becoming an established treatment for end-stage heart failure. In spite of their proven benefit, pump thrombosis remains a significant complication. Here we describe the challenging management of a patient with recurrent pump thrombosis.

Detalles Bibliográficos
Autores principales:	Capoccia, Massimo, Bowles, Christopher T., Sabashnikov, Anton, Simon, Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528789/ https://www.ncbi.nlm.nih.gov/pubmed/26425575 http://dx.doi.org/10.1177/2324709613490676

Ejemplares similares

High fidelity computational simulation of thrombus formation in Thoratec HeartMate II continuous flow ventricular assist device
por: Wu, Wei-Tao, et al.
Publicado: (2016)

Comparison of left ventricular geometry after HeartMate II and HeartWare left ventricular assist device implantation
por: Hosseini, Morteza Tavakkoli, et al.
Publicado: (2013)

Left ventricular assist device exchange from HeartMate II to HeartMate 3 in an Asian patient—a case report and literature review
por: Chang, Hsiao-Huang, et al.
Publicado: (2023)

Infectious complications in patients with ventricular assist device HeartMate II
por: Konarik, M, et al.
Publicado: (2013)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
por: Berardi, Cecilia, et al.
Publicado: (2022)

Recurrent outflow graft compression of HeartMate3: When the left ventricular assist device sticks to the rib
por: Lotan, Dor, et al.
Publicado: (2022)

Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device – the role of anticoagulation
por: van den Bergh, Walter M., et al.
Publicado: (2015)

MediGuide-assisted atrial flutter ablation in a patient with a HeartMate II left ventricular assist device
por: Nguyen Thanh, Hien Kiem, et al.
Publicado: (2015)

Initial Canadian Experience With Bilateral Minithoracotomy Approach for HeartMate 3 Left Ventricular Assist Device Implantation
por: Vasanthan, Vishnu, et al.
Publicado: (2019)

Impact of the HeartMate 3 continuous-flow left ventricular assist device in patients with small body size
por: Tonai, Kohei, et al.
Publicado: (2022)

Long-Term Withdrawal of Anticoagulation and Antiplatelet Therapy in a HeartMate 3 Left Ventricular Assist Device
por: Menchaca, Kristina, et al.
Publicado: (2022)

Conservative initial postoperative anticoagulation strategy after HeartMate 3 left ventricular assist device implantation
por: Damman, Kevin, et al.
Publicado: (2022)

Inflow cannula position as risk factor for stroke in patients with HeartMate 3 left ventricular assist devices
por: Schlöglhofer, Thomas, et al.
Publicado: (2022)

Evaluation of patients with a HeartMate 3 left ventricular assist device using echocardiographic particle image velocimetry
por: Schinkel, Arend F. L., et al.
Publicado: (2020)

Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023)

Survival after HeartMate 3 left ventricular assist device implantation: real‐world data from Europe
por: Numan, Lieke, et al.
Publicado: (2023)

Accuracy of Doppler blood pressure measurement in HeartMate 3 ventricular assist device patients
por: Li, Song, et al.
Publicado: (2020)

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
por: Imamura, Teruhiko, et al.
Publicado: (2020)

Analysis Paralysis: Transition to HeartMate 3 Left Ventricular Assist Device Despite Multiple Complications from COVID-19
por: BhatiaPatel, S., et al.
Publicado: (2022)

Human Factors Evaluation of HeartMate 3 Left Ventricular Assist Device Peripherals: An Eye Tracking Supported Simulation Study
por: Widhalm, Gregor, et al.
Publicado: (2023)

Adverse events with HeartMate-3 Left ventricular assist device: Results from the Manufacturer and User Facility Device Experience (MAUDE) database
por: Heaton, Joseph N., et al.
Publicado: (2021)

Totally percutaneous endovascular repair of HeartMate 3 ventricular assistive device outflow graft pseudoaneurysm
por: Balceniuk, Mark D., et al.
Publicado: (2020)

Commentary: Intraoperative cryoblation during HeartMate 3 left ventricular assist device implantation for refractory ventricular arrhythmias: Ipsa scientia potestas est
por: Altshuler, Peter J., et al.
Publicado: (2020)

Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II
por: Akin, S., et al.
Publicado: (2015)

Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
por: Numan, Lieke, et al.
Publicado: (2021)

Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
por: Elasfar, Abdelfatah, et al.
Publicado: (2018)

Role of left atrial appendage occlusion in patients with HeartMate 3
por: Melehy, Andrew, et al.
Publicado: (2021)

Is flow really continuous in last generation continuous flow Ventricular Assist Devices? A comparison between HeartMate II and HeartWare HVAD
por: Melisurgo, G, et al.
Publicado: (2012)

Use of HeartMate 3 ventricular assist device in second redo sternotomy for congenitally corrected transposition of the great arteries with dextrocardia and situs solitus
por: Knop, Gustavo L., et al.
Publicado: (2022)

HeartMate 3 Implantation via Only Left Thoracotomy: A Case Report
por: Jang, Mi Young, et al.
Publicado: (2023)

Outcomes and Predictors of Early Mortality After Continuous-Flow Left Ventricular Assist Device Implantation as a Bridge to Transplantation
por: Sabashnikov, Anton, et al.
Publicado: (2014)

Principles of HeartMate II Implantation to Avoid Pump Malposition and Migration
por: Adamson, Robert M, et al.
Publicado: (2015)

Does lateral approach preserve the right ventricular function after HeartMate 3 insertion?
por: Hayashi, Hideyuki, et al.
Publicado: (2023)

Primary results of long‐term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants
por: Mehra, Mandeep R., et al.
Publicado: (2021)

Ruptured hemorrhagic bulla in a patient with a HeartMate 3 treated with an Amplatzer device
por: daSilva-deAbreu, Adrian, et al.
Publicado: (2021)

Validation of non‐invasive ramp testing for HeartMate 3
por: Najjar, Emil, et al.
Publicado: (2020)

Electrostatic Discharge Causing Pump Shutdown in HeartMate 3
por: Najjar, Emil, et al.
Publicado: (2021)

Intraoperative pump thrombosis (PT) in HeartMate (HM) III
por: Karuppiah, Sathappan, et al.
Publicado: (2022)

HeartMate III as a Bridge to Transplantation in an Adolescent With Failed Fontan Circulation
por: Marey, Gamal, et al.
Publicado: (2019)

Aortic Root Thrombus Directly After Left Ventricular Assist Device Implantation
por: Mork, Constantin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1f3hpn41gjedtg2nrfg0878u1s